GE HealthCare Technologies Inc. Price, Chart & Factor Exposure
Free Data & Analytics AccessLatest earnings: October 28, 2026 results vs estimates
GE HealthCare Technologies Inc. Forecast
GE HealthCare Technologies Inc. short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 32.5% a year, a typical one-standard-deviation range is 72.92–79.92 over a week, 69.24–83.60 over a month and 51.55–101.29 over a year. (Signals as of 1 Nov 2026.)
GE HealthCare Technologies Inc. Price Chart
GE HealthCare Technologies Inc. Factors
YoY +1.4%
YoY −7.3%
YoY −14.7%
YoY +0.7%
YoY −5.3%
YoY +36.2%
YoY −1.4%
YoY +4.2%
YoY −0.9%
YoY +12.1%
YoY +11.6%
YoY +10.4%
YoY +5.7%
YoY +3.7%
YoY −16.6%
YoY +40.0%
YoY +2.4%
GE HealthCare Technologies Inc. fundamentals: income statement, balance sheet & cash flow
GE HealthCare Technologies Inc. reported revenue of $20.63bn and net income of $2.08bn in FY2025, the year ended 31 December 2025 — revenue up 4.8% and net income up 4.6% on the prior year. Free cash flow was $1.51bn. These figures are as reported in the filings, not restated: 7 fiscal years and 23 quarters of history, back to December 2019. 90 FINRA short-interest settlements are published alongside them, back to January 2023.
| USD billions | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
| Revenue | 20.63 | 19.67 | 19.55 | 18.34 | 17.59 |
| Cost of revenue | 12.38 | 11.47 | 11.63 | 11.16 | 10.41 |
| Gross profit | 8.25 | 8.21 | 7.92 | 7.18 | 7.17 |
| Research & development | 1.26 | 1.31 | 1.21 | 1.03 | 0.82 |
| Selling, general & admin. | — | 4.27 | 4.28 | 3.63 | 3.56 |
| Operating income | 2.76 | 2.63 | 2.44 | 2.52 | 2.80 |
| EBITDA | 3.79 | 3.67 | 2.44 | 3.17 | 3.54 |
| Interest expense | 0.45 | 0.51 | 0.54 | 0.09 | 0.04 |
| Pre-tax income | 2.77 | 2.58 | 2.36 | 2.51 | 2.88 |
| Income tax | 0.61 | 0.53 | -0.74 | 0.56 | 0.60 |
| Net income | 2.08 | 1.99 | 3.10 | 1.92 | 2.25 |
Download GE HealthCare Technologies Inc. fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.GEHC.NASDAQ&statement=all&freq=a&format=csv&years=10
Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.
Research on GE HealthCare Technologies Inc.
Explore MacroFinance macro & markets research and analysis.
GE HealthCare Technologies Inc. Trading Strategies
58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to GE HealthCare Technologies Inc.; 28 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in SPY, XLV | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Tactical Permanent Portfolio | Conservative | Monthly | Premium · upgrade to view | |||
| Zakamulin and Giner's Optimal Trend Following | Moderate | Monthly | Premium · upgrade to view | |||
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Harry Browne's Permanent Portfolio | Conservative | Monthly | 25% | 7.0% | 0.96 | -17.2% |
| Keller and Van Putten's Flexible Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Ned Davis' Three Way Model | Moderate | Monthly | Premium · upgrade to view | |||
| 60_40 Benchmark | Moderate | Monthly | 60% | 8.2% | 0.93 | -29.5% |
| Dick Stoken's Active Combined Asset (ACA) - Monthly Trading | Moderate | Monthly | Premium · upgrade to view | |||
| PortfolioCharts' Golden Butterfly | Moderate | Monthly | 20% | 7.4% | 0.91 | -18.0% |
| US Cross-Asset Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
From creators
- P4 Demo Momentum by admin
- strategyx by admin
Statistical Distribution of Returns
PlusHow GE HealthCare Technologies Inc.’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About GE HealthCare Technologies Inc. (United States)
GE HealthCare Technologies Inc. is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
Frequently asked questions
What is GE HealthCare Technologies Inc.?
What is the latest GE HealthCare Technologies Inc. price?
Is GE HealthCare Technologies Inc. in an uptrend?
How volatile is GE HealthCare Technologies Inc.?
What factors affect GE HealthCare Technologies Inc.?
Which trading strategies trade GE HealthCare Technologies Inc.?
How are GE HealthCare Technologies Inc. returns analysed?
Where can I download free GE HealthCare Technologies Inc. historical data?
Free GE HealthCare Technologies Inc. historical data (last 10 years)
Browse or instantly download the last 10 years of GE HealthCare Technologies Inc. daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.GEHC.NASDAQ&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 80.64 |
| 2026-11-19 | 81.89 |
| 2026-11-18 | 83.66 |
| 2026-11-17 | 81.84 |
| 2026-11-16 | 82.96 |
| 2026-11-13 | 83.02 |
| 2026-11-12 | 81.84 |
| 2026-11-11 | 82.6 |
| 2026-11-10 | 83.65 |
| 2026-11-09 | 84.03 |
About this stock
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.